SubscribeDespite the harsh effects of the Asian financial crisis, pharmaceutical markets in Asia still have a bright future. Thailand's pharmaceutical market in particular suffered drops in 1997 and 1998 but renewed consumer demand and increased incomes are helping rebound the Thai pharmaceutical market growth rate.
The Food and Drug Administration (FDA), under the Ministry of Public Health (MOPH), is working to revise the regulatory situation for pharmaceuticals entering the Thai market. The MOPH is making an effort to revise its drug classification system, regulatory procedures, pricing and competition controls, marketing regulations, and intellectual property protections in order to liberalize the market and minimize corruption.
Thailand’s pharmaceutical market last year expanded 17% to about 50 Billion baht, with foreign drug makers accounting for 70% of the sales and for this year, the industry is expected to grow at a slightly lower rate of 14-15%. While the drugstore business expanded at a relatively slow growth of 6%-7% over the last 5 years due to the state-sponsored universal health program, medicines sold to hospitals saw a significant growth of about 17-18% due to the availability of new drugs and drugs for special treatments.
In line with the continuing growth of Thailand’s well-developed and dynamic pharmaceutical sector, government policy to promote Thailand as Asia’s healthcare hub, the ongoing state support for the 30-baht health scheme, and emerging industry challenges resulting from new market innovations and the introduction of FTAs, this Pharmaceutical Industry in Thailand conference aims to provide essential updates on current developments, regulatory perspectives and market growth prospects in the exciting pharmaceutical market in Thailand.
The Pharmaceutical Industry in Thailand Conference will offer you an unrivalled opportunity to keep abreast of the latest market updates and investment opportunities. Grasp this rare chance to establish valuable contacts, network with key decision-makers and acquire 1st hand strategic and market information that you need to make profitable investment decisions.
KEY BENEFITS OF ATTENDING THIS TIMELY FORUM
ØMeetthe nation’s top-caliber decision makers and be updated on government policies, drug regulations and key legislative changes in the pharmaceutical sector
ØObtainfirst-hand information on market overviews, demand forecasts, key drivers for market growth, a strategic level analysis of challenges facing Thailand’s pharmaceutical
Øindustry as well as implications for international and local players
ØCapitalizeon emerging and new opportunities in this rapidly changing industry
ØInvestigatethe most effective distribution channel in the Thai pharmaceuticals market
ØExaminethe latest strategies in salesforce effectiveness and learn effective tools in managing field force performance
Broaden your network with highprofile authorities, industry experts and renew your contacts with your peers in the pharmaceutical and health care industry.
For more information please contact:
Asia Business Forum (Thailand) Ltd
14/F Maneeya Center Building, 518/5 Ploenchit Road
Lumpini, Pathumwan, Bangkok 10330, Thailand
Website: www.abf-asia.com
Contact: Ms. Pawarin
Tel: +66 (0) 2254-8275, 2548321-4
Fax: +66 (0) 2254 8320
Email: mktg.bkk1@abf-asia.com